Correction: SPAG6 hypermethylation silences a novel tumor suppressor and inhibits renal cell carcinoma progression via PI3K/AKT/mTOR pathway
Tianyu Wu, Xing Ji, Yongyang Yun, Xiaofei Wang, Ying Gan, Yu Fan, Qian Zhang
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer, Hypoxia, and Metabolism · PI3K/AKT/mTOR signaling in cancer · Epigenetics and DNA Methylation
There are errors in the author affiliations. The correct affiliations are as follows:
Tianyu Wu ^1,2,3,4^, Xing Ji ^1,2,3,4^, Yongyang Yun ^1,2,3,4^, Xiaofei Wang ^5^, Ying Gan ^1,2,3,4^, Yu Fan ^1,2,3,4^, Qian Zhang ^1,2,3,4,6^
1 Department of Urology, Peking University First Hospital, Beijing, China, 2 Institution of Urology, Peking University, Beijing, China, 3 Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, China, 4 National Urological Cancer Center, Beijing, China, 5 Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China, 6 Department of Urology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
The reference list from the paper itself. Each links out to its DOI / PubMed record.